Advertisement
Amylyx Pharmaceuticals, Inc. (AMLX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 5.19 |
| Open | 5.33 |
| Bid | 5.24 x 200 |
| Ask | 5.30 x 500 |
| Day's Range | 5.15 - 5.40 |
| 52 Week Range | 1.58 - 19.95 |
| Volume | |
| Avg. Volume | 1,450,162 |
| Market Cap | 361.247M |
| Beta (5Y Monthly) | -0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.82 |
| Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.50 |
Simply Wall St.Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)
Amylyx Pharmaceuticals ( NASDAQ:AMLX ) Third Quarter 2024 Results Key Financial Results Revenue: US$416.0k (down 100...
- GuruFocus.com
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
Amylyx Pharmaceuticals Inc (AMLX) showcases promising clinical progress and a strong cash position, despite facing revenue shortfalls and regulatory hurdles.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.